Salivary Markers in Patients With Xerostomia

Xerostomia Due to Hyposecretion of Salivary Gland Clinical Trial

Official title:
Oral Health and Salivary Markers in Patients With Xerostomia

Status Completed

Clinical Trial Summary

The purpose of this study was to investigate the salivary levels of inflammatory and their association with oral health in xerostomía patient

Clinical Trial Description

Primary Outcome Measures:

- salivary Proinflammatory and anti-inflammatory cytokines

- questionnaire is provided to the patient for xerostomia characterization

Secondary Outcome Measures:

- Probing pocket depth

- Probing pocket depth and clinical attachment level

- Gingival index

- Plaque index

- Bleeding on probing ;

Study Design

Related Conditions & MeSH terms

Xerostomia
Xerostomia Due to Hyposecretion of Salivary Gland

Clinical Trial Details

NCT number	NCT03156569
Study type	Observational [Patient Registry]
Source	Universidad de Murcia
Contact
Status	Completed
Phase	N/A
Start date	January 2016
Completion date	October 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03452085` - The Artificial Saliva Spray Reduces Xerostomia in Diabetes Type II	N/A
Not yet recruiting	`NCT03530735` - Finger-prick Autologous Blood (FAB) for Use in Dry Mouth	N/A
Completed	`NCT03612414` - Efficacy of a Dietary Supplement (Aqualief®) in Xerostomic Patients	N/A
Completed	`NCT06114797` - Chamomile Effect on Xerostomia Associated With End-stage Renal Disease in Elderly	N/A